FDA approves generic versions of controversial OxyContin

OxyContin may now go generic, U.S. regulators have ruled, but only if Teva Pharmaceuticals and Endo Pharmaceutical Holdings, whose products were approved, take steps to prevent illegal use of the drug. OxyContin, a strong opioid painkiller, is made by Purdue Pharma, which instigated procedures to prevent abuse by users who crushed the pill and took it all at once to get a high instead of allowing it to be dispensed by a time-release method, as intended.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
In house Compliance Officer
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC